19 November, 2018 in Business Economics, Commentary, Healthcare / 0 Comments The Bizarre World of Drug Pricing
16 November, 2018 in Business Economics, Commentary, Healthcare / 0 Comments New Medicare Price Controls Don’t Put America First
15 November, 2018 in Business Economics, Commentary / 0 Comments The Law of Unintended Consequences: The Case of Proxy Advisory Firms
25 October, 2018 in Blog, Business Economics, Healthcare / 0 Comments Does President Trump Favor Price Controls?
24 October, 2018 in Business Economics, Commentary, Healthcare / 0 Comments Repeal the Medical Device Tax
18 October, 2018 in Business Economics, Commentary, Healthcare / 0 Comments The benefits of repealing the medical device tax
17 October, 2018 in Commentary, Healthcare / 0 Comments Requiring That Drug Advertisements Include List Prices Promotes Misinformation
24 September, 2018 in Blog, Environment / 0 Comments Why the Two Orders? Freezing CAFE standards was the correct policy
20 September, 2018 in Business Economics, California, Commentary / 0 Comments The Opportunity Created by California’s Overly-Generous Public Pensions
